e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ESR/ERS white paper on lung cancer screening
Kauczor Hans-Ulrich, Bonomo Lorenzo, Gaga Mina, Nackaerts Kristiaan, Peled Nir, Prokop Mathias, Remy-Jardin Martine, von Stackelberg Oyunbileg, Sculier Jean-Paul
Source:
Eur Respir J 2015; 46: 28-39
Journal Issue:
July
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kauczor Hans-Ulrich, Bonomo Lorenzo, Gaga Mina, Nackaerts Kristiaan, Peled Nir, Prokop Mathias, Remy-Jardin Martine, von Stackelberg Oyunbileg, Sculier Jean-Paul. ESR/ERS white paper on lung cancer screening. Eur Respir J 2015; 46: 28-39
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
ESR/ERS statement paper on lung cancer screening
Source: Guideline 2020
Year: 2020
ESR/ERS statement paper on lung cancer screening
Source: Eur Respir J, 55 (2) 1900506; 10.1183/13993003.00506-2019
Year: 2020
The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018
Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007
Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007
Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Evolution in the diagnostic approach to lung cancer
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Evolution in the pathological study of lung cancer
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020
Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Screening for lung cancer
Source: International Congress 2017 – Lung cancer for the pulmonologist
Year: 2017
Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
Lung cancer screening white paper: a slippery step forward?
Source: Eur Respir J 2015; 46: 1519-1520
Year: 2015
Lung cancer screening white paper: a slippery step forward?
Source: Eur Respir J 2015; 46: 1521-1522
Year: 2015
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept